Lineage, Inc. Common Stock (LINE)vsStar Holdings (STHO)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
STHO
Star Holdings
$9.31
-2.31%
REAL ESTATE · Cap: $117.62M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 5366% more annual revenue ($5.37B vs $98.27M). STHO leads profitability with a 14.1% profit margin vs -3.1%. STHO earns a higher WallStSmart Score of 39/100 (F).
LINE
Avoid35
out of 100
Grade: F
STHO
Hold39
out of 100
Grade: F
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Intrinsic value data unavailable for LINE.
Margin of Safety
-66.2%
Fair Value
$4.82
Current Price
$9.31
$4.49 premium
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Smaller company, higher risk/reward
Operating margin of 3.1%
ROE of -28.0% — below average capital efficiency
Revenue declined 59.9%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : STHO
The strongest argument for STHO centers on P/E Ratio, Price/Book.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : STHO
The primary concerns for STHO are Market Cap, Operating Margin, Return on Equity.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while STHO is a declining play — different risk/reward profiles.
STHO carries more volatility with a beta of 1.21 — expect wider price swings.
LINE is growing revenue faster at 0.8% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
STHO scores higher overall (39/100 vs 35/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Star Holdings
REAL ESTATE · REAL ESTATE SERVICES · USA
Star Holdings engages in the non-ground lease related commercial real estate businesses in the United States. The company is headquartered in New York, New York.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?